HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.

AbstractOBJECTIVE:
To evaluate the clinical efficacy and safety of HYAFF 11-based autologous dermal and epidermal grafts in the management of diabetic foot ulcers.
RESEARCH DESIGN AND METHODS:
A total of 79 patients with diabetic dorsal (n = 37) or plantar (n = 42) ulcers were randomized to either the control group with nonadherent paraffin gauze (n = 36) or the treatment group with autologous tissue-engineered grafts (n = 43). Weekly assessment, aggressive debridement, wound infection control, and adequate pressure relief (fiberglass off-loading cast for plantar ulcers) were provided in both groups. Complete wound healing was assessed within 11 weeks. Safety was monitored by adverse events.
RESULTS:
Complete ulcer healing was achieved in 65.3% of the treatment group and 49.6% of the control group (P = 0.191). The Kaplan-Meier mean time to closure was 57 and 77 days, respectively, for the treatment versus control groups. Plantar foot ulcer healing was 55% and 50% in the treatment and control groups, respectively. Dorsal foot ulcer healing was significantly different, with 67% in the treatment group and 31% in the control group (P = 0.049). The mean healing time in the dorsal treatment group was 63 days, and the odds ratio for dorsal ulcer healing compared with the control group was 4.44 (P = 0.037). Adverse events were equally distributed between the two groups, and none were related to the treatments.
CONCLUSIONS:
The autologous tissue-engineered treatment exhibited improved healing in dorsal ulcers when compared with the current standard dressing. For plantar ulcers, the off-loading cast was presumably paramount and masked or nullified the effects of the autologous wound treatment. This treatment, however, may be useful in patients for whom the total off-loading cast is not recommended and only a less effective off-loading device can be applied.
AuthorsCarlo Caravaggi, Roberto De Giglio, Chiara Pritelli, Manuela Sommaria, Sergio Dalla Noce, Ezio Faglia, Manuela Mantero, Giacomo Clerici, Pietro Fratino, Luca Dalla Paola, Giulio Mariani, Roberto Mingardi, Alberto Morabito
JournalDiabetes care (Diabetes Care) Vol. 26 Issue 10 Pg. 2853-9 (Oct 2003) ISSN: 0149-5992 [Print] United States
PMID14514591 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • hyaluronic acid benzyl ester
  • Paraffin
  • Hyaluronic Acid
Topics
  • Bandages (adverse effects)
  • Combined Modality Therapy
  • Dermis (transplantation)
  • Diabetic Foot (drug therapy, surgery)
  • Epidermis (transplantation)
  • Humans
  • Hyaluronic Acid (administration & dosage, adverse effects, analogs & derivatives)
  • Infections
  • Paraffin
  • Prospective Studies
  • Skin Transplantation
  • Transplantation, Autologous
  • Treatment Outcome
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: